NCT06259552
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06259552
Title A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)
Acronym SPX-303
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SparX Biotech(Jiangsu) Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona RECRUITING Phoenix Arizona 85054 United States Details
HonorHealth Research and Innovation Institute RECRUITING Scottsdale Arizona 85258 United States Details
Mayo Clinic Florida RECRUITING Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester RECRUITING Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field